Skip to main content Accessibility help
  • Print publication year: 2014
  • Online publication date: May 2014

Chapter 31 - Cellular replacement in spinal cord injury

from Section 6 - Promotion of regeneration in the injured nervous system

Related content

Powered by UNSILO


1. HouleJD, TesslerA. Repair of chronic spinal cord injury. Exp Neurol 2003; 182: 247–60.
2. Christopher & Dana Reeve Foundation. Paralysis Facts and Figures 2010 [cited March 1 2011]. Available from:
3. van den BergME, CastelloteJM, de Pedro-CuestaJ, et al. Survival after spinal cord injury: a systematic review. J Neurotrauma 2010; 27: 1517–28.
4. KakulasBA. A review of the neuropathology of human spinal cord injury with emphasis on special features. J Spinal Cord Med 1999; 22: 119–24.
5. ChenMS, HuberAB, van der HaarME, et al. Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature 2000; 403: 434–9.
6. TangX, DaviesJE, DaviesSJA. Changes in distribution, cell associations, and protein expression levels of NG2, neurocan, phosphacan, brevican, versican V2, and tenascin-C during acute to chronic maturation of spinal cord scar tissue. J Neurosci Res 2003; 71: 427–44.
7. FilbinMT. Myelin-associated inhibitors of axonal regeneration in the adult mammalian CNS. Nat Rev Neurosci 2003; 4: 703–13.
8. BungeRP, PuckettWR, BecerraJL, et al. Observations on the pathology of human spinal cord injury. A review and classification of 22 new cases with details from a case of chronic cord compression with extensive focal demyelination. Adv Neurol 1993; 59: 75–89.
9. NashmiR, FehlingsMG. Mechanisms of axonal dysfunction after spinal cord injury: with an emphasis on the role of voltage-gated potassium channels. Brain Res Brain Res Rev 2001; 38: 165–91.
10. KwonBK, OkonEB, PlunetW, et al. A systematic review of directly applied biologic therapies for acute spinal cord injury. J Neurotrauma 2011; 28: 1589–610.
11. TetzlaffW, OkonEB, Karimi-AbdolrezaeeS, et al. A systematic review of cellular transplantation therapies for spinal cord injury. J Neurotrauma 2011; 28: 1611–82.
12. ShibayamaM, HattoriS, HimesBT, et al. Neurotrophin-3 prevents death of axotomized Clarke’s nucleus neurons in adult rat. J Comp Neurol 1998; 390: 102–11.
13. RossignolS, GirouxN, ChauC, et al. Pharmacological aids to locomotor training after spinal injury in the cat. J Physiol 2001; 533: 65–74.
14. BradburyEJ, MoonLD, PopatRJ, et al. Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature 2002; 416: 636–40.
15. PotterPJ, HayesKC, SegalJL, et al. Randomized double-blind crossover trial of fampridine-SR (sustained release 4-aminopyridine) in patients with incomplete spinal cord injury. J Neurotrauma 1998; 15: 837–49.
16. BareyreFM, KerschensteinerM, RaineteauO, et al. The injured spinal cord spontaneously forms a new intraspinal circuit in adult rats. Nat Neurosci 2004; 7: 269–77.
17. ChenJ, MagaviSS, MacklisJD. Neurogenesis of corticospinal motor neurons extending spinal projections in adult mice. Proc Natl Acad Sci U S A 2004; 101: 16357–62.
18. LiuXZ, XuXM, HuR, et al. Neuronal and glial apoptosis after traumatic spinal cord injury. J Neurosci 1997; 17: 5395–406.
19. KalyaniAJ, PiperD, MujtabaT, et al. Spinal cord neuronal precursors generate multiple neuronal phenotypes in culture. J Neurosci 1998; 18: 7856–68.
20. GiovaniniMA, ReierPJ, EskinTA, et al. Characteristics of human fetal spinal cord grafts in the adult rat spinal cord: influences of lesion and grafting conditions. Exp Neurol 1997; 148: 523–43.
21. TheeleDP, SchrimsherGW, ReierPJ. Comparison of the growth and fate of fetal spinal iso- and allografts in the adult rat injured spinal cord. Exp Neurol 1996; 142: 128–43.
22. LittT, DerbolavJ, NicolinF. Geist und Erziehung : aus dem Gespräch zwischen Philosophie und Pädagogik : kleine Bonner Festgabe für Theodor Litt. Bonn: H. Bouvier, 1955; xii: 224.
23. LeporeAC, FischerI. Lineage-restricted neural precursors survive, migrate, and differentiate following transplantation into the injured adult spinal cord. Exp Neurol 2005; 194: 230–42.
24. ItohY, TesslerA. Ultrastructural organization of regenerated adult dorsal root axons within transplants of fetal spinal cord. J Comp Neurol 1990; 292: 396–411.
25. HouleJD, SkinnerRD, Garcia-RillE, et al. Synaptic evoked potentials from regenerating dorsal root axons within fetal spinal cord tissue transplants. Exp Neurol 1996; 139: 278–90.
26. WhiteTE, LaneMA, SandhuMS, et al. Neuronal progenitor transplantation and respiratory outcomes following upper cervical spinal cord injury in adult rats. Exp Neurol 2010; 225: 231–6.
27. HimesBT, LiuY, SolowskaJM, et al. Transplants of cells genetically modified to express neurotrophin-3 rescue axotomized Clarke’s nucleus neurons after spinal cord hemisection in adult rats. J Neurosci Res 2001; 65: 549–64.
28. MoriF, HimesBT, KowadaM, et al. Fetal spinal cord transplants rescue some axotomized rubrospinal neurons from retrograde cell death in adult rats. Exp Neurol 1997; 143: 45–60.
29. HouleJ. The structural integrity of glial scar tissue associated with a chronic spinal cord lesion can be altered by transplanted fetal spinal cord tissue. J Neurosci Res 1992; 31: 120–30.
30. HouleJD, MorrisK, SkinnerRD, et al. Effects of fetal spinal cord tissue transplants and cycling exercise on the soleus muscle in spinalized rats. Muscle Nerve 1999; 22: 846–56.
31. BeaumontE, HouleJD, PetersonCA, et al. Passive exercise and fetal spinal cord transplant both help to restore motoneuronal properties after spinal cord transection in rats. Muscle Nerve 2004; 29: 234–42.
32. CoumansJV, LinTT, DaiHN, et al. Axonal regeneration and functional recovery after complete spinal cord transection in rats by delayed treatment with transplants and neurotrophins. J Neurosci 2001; 21: 9334–44.
33. ThompsonFJ, ReierPJ, UthmanB, MottS, FesslerRG, BehrmanA, et al. Neurophysiological assessment of the feasibility and safety of neural tissue transplantation in patients with syringomyelia. J Neurotrauma 2001; 18: 931–45.
34. WirthED, ReierPJ, FesslerRG, et al. Feasibility and safety of neural tissue transplantation in patients with syringomyelia. J Neurotraum 2001; 18: 911–29.
35. ReierPJ, BregmanBS, WujekJR. Intraspinal transplantation of embryonic spinal cord tissue in neonatal and adult rats. J Comp Neurol 1986; 247: 275–96.
36. GaillardA, PrestozL, DumartinB, et al. Reestablishment of damaged adult motor pathways by grafted embryonic cortical neurons. Nat Neurosci 2007; 10: 1294–9.
37. Gimenez y RibottaM, PrivatA. Biological interventions for spinal cord injury. Curr Opin Neurol 1998; 11: 647–54.
38. GageFH. Mammalian neural stem cells. Science 2000; 287: 1433–8.
39. TempleS. The development of neural stem cells. Nature 2001; 414: 112–17.
40. KalyaniAJ, RaoMS. Cell lineage in the developing neural tube. Biochem Cell Biol 1998; 76: 1051–68.
41. ShinS, MitalipovaM, NoggleS, et al Long-term proliferation of human embryonic stem cell-derived neuroepithelial cells using defined adherent culture conditions. Stem Cells 2006; 24: 125–38.
42. RossiSL, KeirsteadHS. Stem cells and spinal cord regeneration. Curr Opin Biotechnol 2009; 20: 552–62.
43. KalyaniA, HobsonK, RaoMS. Neuroepithelial stem cells from the embryonic spinal cord: isolation, characterization, and clonal analysis. Dev Biol 1997; 186: 202–23.
44. Mayer-ProschelM, KalyaniAJ, MujtabaT, et al. Isolation of lineage-restricted neuronal precursors from multipotent neuroepithelial stem cells. Neuron 1997; 19: 773–85.
45. RaoMS, Mayer-ProschelM. Glial-restricted precursors are derived from multipotent neuroepithelial stem cells. Dev Biol 1997; 188: 48–63.
46. RaoMS, NobleM, Mayer-ProschelM. A tripotential glial precursor cell is present in the developing spinal cord. Proc Natl Acad Sci U S A 1998; 95: 3996–4001.
47. LiuY, RaoMS. Glial progenitors in the CNS and possible lineage relationships among them. Biol Cell 2004; 96: 279–90.
48. WeissS, DunneC, HewsonJ, et al. Multipotent CNS stem cells are present in the adult mammalian spinal cord and ventricular neuroaxis. J Neurosci 1996; 16: 7599–609.
49. JohanssonCB, MommaS, ClarkeDL, et al. Identification of a neural stem cell in the adult mammalian central nervous system. Cell 1999; 96: 25–34.
50. PevnyL, RaoMS. The stem-cell menagerie. Trends Neurosci 2003; 26: 351–9.
51. UchidaN, BuckDW, HeD, et al. Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci U S A 2000; 97: 14720–5.
52. YanJ, XuL, WelshAM, et al. Extensive neuronal differentiation of human neural stem cell grafts in adult rat spinal cord. PLoS Med 2007; 4: e39.
53. SeeJ, BonnerJF, NeuhuberB, et al. Neurite outgrowth of neural progenitors in presence of inhibitory proteoglycans. J Neurotrauma 2010; 27: 951–7.
54. LiR, ThodeS, ZhouJ, et al. Motoneuron differentiation of immortalized human spinal cord cell lines. J Neurosci Res 2000; 59: 342–52.
55. MujtabaT, PiperDR, KalyaniA, et al. Lineage-restricted neural precursors can be isolated from both the mouse neural tube and cultured ES cells. Dev Biol 1999; 214: 113–27.
56. LuskinMB. Restricted proliferation and migration of postnatally generated neurons derived from the forebrain subventricular zone. Neuron 1993; 11: 173–89.
57. RoyNS, BenraissA, WangS, et al. Promoter-targeted selection and isolation of neural progenitor cells from the adult human ventricular zone. J Neurosci Res 2000; 59: 321–31.
58. LeeJC, Mayer-ProschelM, RaoMS. Gliogenesis in the central nervous system. Glia 2000; 30: 105–21.
59. DietrichJ, NobleM, Mayer-ProschelM. Characterization of A2B5+ glial precursor cells from cryopreserved human fetal brain progenitor cells. Glia 2002; 40: 65–77.
60. SandrockRW, WheatleyW, LevinthalC, et al. Isolation, characterization and preclinical development of human glial-restricted progenitor cells for treatment of neurological disorders. Regen Med 2010; 5: 381–94.
61. RaffMC, MillerRH, NobleM. A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium. Nature 1983; 303: 390–6.
62. Espinosa de los MonterosA, ZhangM, De VellisJ. O2A progenitor cells transplanted into the neonatal rat brain develop into oligodendrocytes but not astrocytes. Proc Natl Acad Sci U S A 1993; 90: 50–4.
63. MillerRH. Regulation of oligodendrocyte development in the vertebrate CNS. Prog Neurobiol 2002; 67: 451–67.
64. MiH, BarresBA. Purification and characterization of astrocyte precursor cells in the developing rat optic nerve. J Neurosci 1999; 19: 1049–61.
65. KeirsteadHS, Ben-HurT, RogisterB, et al. Polysialylated neural cell adhesion molecule-positive CNS precursors generate both oligodendrocytes and Schwann cells to remyelinate the CNS after transplantation. J Neurosci 1999; 19: 7529–36.
66. MartinGR. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci U S A 1981; 78: 7634–8.
67. BuehrM, MeekS, BlairK, et al. Capture of authentic embryonic stem cells from rat blastocysts. Cell 2008; 135: 1287–98.
68. ThomsonJA, Itskovitz-EldorJ, ShapiroSS, et al. Embryonic stem cell lines derived from human blastocysts. Science 1998; 282: 1145–7.
69. ThomsonJA, KalishmanJ, GolosTG, et al. Isolation of a primate embryonic stem cell line. Proc Natl Acad Sci U S A 1995; 92: 7844–8.
70. NakatsujiN, SuemoriH. Embryonic stem cell lines of nonhuman primates. Scientific World Journal 2002; 2: 1762–73.
71. BradleyA, EvansM, KaufmanMH, et al. Formation of germ-line chimaeras from embryo-derived teratocarcinoma cell lines. Nature 1984; 309: 255–6.
72. HirabayashiM, KatoM, KobayashiT, et al. Establishment of rat embryonic stem cell lines that can participate in germline chimerae at high efficiency. Mol Reprod Dev 2010; 77: 94.
73. TakahashiK, YamanakaS. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126: 663–76.
74. TakahashiK, TanabeK, OhnukiM, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131: 861–72.
75. OkitaK, NakagawaM, HyenjongH, et al. Generation of mouse induced pluripotent stem cells without viral vectors. Science 2008; 322: 949–53.
76. NakagawaM, KoyanagiM, TanabeK, et al. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol 2008; 26: 101–6.
77. ZhouH, WuS, JooJY, et al. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 2009; 4: 381–4.
78. KocheRP, SmithZD, AdliM, et al. Reprogramming factor expression initiates widespread targeted chromatin remodeling. Cell Stem Cell 2011; 8: 96–105.
79. ListerR, PelizzolaM, KidaYS, et al. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature 2011; 471: 68–73.
80. HuQ, FriedrichAM, JohnsonLV, CleggDO. Memory in induced pluripotent stem cells: reprogrammed human retinal-pigmented epithelial cells show tendency for spontaneous redifferentiation. Stem Cells 2010; 28: 1981–91.
81. ParkIH, AroraN, HuoH, et al. Disease-specific induced pluripotent stem cells. Cell 2008; 134: 877–86.
82. InoueH. Neurodegenerative disease-specific induced pluripotent stem cell research. Exp Cell Res 2010; 316: 2560–4.
83. KobayashiY, OkadaY, ItakuraG, et al. Pre-evaluated safe human iPSC-derived neural stem cells promote functional recovery after spinal cord injury in common marmoset without tumorigenicity. PLoS One 2012; 7: e52787.
84. FujimotoY, AbematsuM, FalkA, et al. Treatment of a mouse model of spinal cord injury by transplantation of human induced pluripotent stem cell-derived long-term self-renewing neuroepithelial-like stem cells. Stem Cells 2012; 30: 1163–73.
85. NoriS, OkadaY, YasudaA, et al. Grafted human-induced pluripotent stem-cell-derived neurospheres promote motor functional recovery after spinal cord injury in mice. Proc Natl Acad Sci U S A 2011; 108: 16825–30.
86. WichterleH, LieberamI, PorterJA, et al. Directed differentiation of embryonic stem cells into motor neurons. Cell 2002; 110: 385–97.
87. LiXJ, ZhangX, JohnsonMA, et al. Coordination of sonic hedgehog and Wnt signaling determines ventral and dorsal telencephalic neuron types from human embryonic stem cells. Development 2009; 136: 4055–63.
88. KeirsteadHS, NistorG, BernalG, et al. Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J Neurosci 2005; 25: 4694–705.
89. OkunoT, NakayamaT, KonishiN, et al. Self-contained induction of neurons from human embryonic stem cells. PLoS One 2009; 4: e6318.
90. McDonaldJW, LiuXZ, QuY, et al. Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord. Nat Med 1999; 5: 1410–12.
91. ZhaoT, ZhangZN, RongZ, et al. Immunogenicity of induced pluripotent stem cells. Nature 2011; 474: 212–15.
92. HornerPJ, PowerAE, KempermannG, et al. Proliferation and differentiation of progenitor cells throughout the intact adult rat spinal cord. J Neurosci 2000; 20: 2218–28.
93. ShihabuddinLS, HornerPJ, RayJ, et al. Adult spinal cord stem cells generate neurons after transplantation in the adult dentate gyrus. J Neurosci 2000; 20: 8727–35.
94. KimSU, de VellisJ. Stem cell-based cell therapy in neurological diseases: a review. J Neurosci Res 2009; 87: 2183–200.
95. LindvallO, KokaiaZ. Stem cells in human neurodegenerative disorders–time for clinical translation? J Clin Invest 2010; 120: 29–40.
96. CaoQL, ZhangYP, HowardRM, et al. Pluripotent stem cells engrafted into the normal or lesioned adult rat spinal cord are restricted to a glial lineage. Exp Neurol 2001; 167: 48–58.
97. OgawaY, SawamotoK, MiyataT, et al. Transplantation of in vitro-expanded fetal neural progenitor cells results in neurogenesis and functional recovery after spinal cord contusion injury in adult rats. J Neurosci Res 2002; 69: 925–33.
98. MitsuiT, KakizakiH, TanakaH, et al. Immortalized neural stem cells transplanted into the injured spinal cord promote recovery of voiding function in the rat. J Urol 2003; 170: 1421–5.
99. ChowSY, MoulJ, TobiasCA, et al. Characterization and intraspinal grafting of EGF/bFGF-dependent neurospheres derived from embryonic rat spinal cord. Brain Res 2000; 874: 87–106.
100. HofstetterCP, HolmstromNA, LiljaJA, et al. Allodynia limits the usefulness of intraspinal neural stem cell grafts; directed differentiation improves outcome. Nat Neurosci 2005; 8: 346–53.
101. TarasenkoYI, GaoJ, NieL, et al. Human fetal neural stem cells grafted into contusion-injured rat spinal cords improve behavior. J Neurosci Res 2007; 85: 47–57.
102. IwanamiA, KanekoS, NakamuraM, et al. Transplantation of human neural stem cells for spinal cord injury in primates. J Neurosci Res 2005; 80: 182–90.
103. TropepeV, SibiliaM, CirunaBG, et al. Distinct neural stem cells proliferate in response to EGF and FGF in the developing mouse telencephalon. Dev Biol 1999; 208: 166–88.
104. LeporeAC, HanSS, Tyler-PolszCJ, et al. Differential fate of multipotent and lineage-restricted neural precursors following transplantation into the adult CNS. Neuron Glia Biol 2004; 1: 113–26.
105. LowryN, GoderieSK, AdamoM, et al. Multipotent embryonic spinal cord stem cells expanded by endothelial factors and Shh/RA promote functional recovery after spinal cord injury. Exp Neurol 2008; 209: 510–22.
106. SalazarDL, UchidaN, HamersFP, et al. Human neural stem cells differentiate and promote locomotor recovery in an early chronic spinal cord injury NOD-scid mouse model. PLoS One 2010; 5: e12272.
107. FranklinRJ, Ffrench-Constant C. Remyelination in the CNS: from biology to therapy. Nat Rev Neurosci 2008; 9: 839–55.
108. SasakiM, LiB, LankfordKL, et al. Remyelination of the injured spinal cord. Prog Brain Res 2007; 161: 419–33.
109. ZhangSC, GeB, DuncanID. Adult brain retains the potential to generate oligodendroglial progenitors with extensive myelination capacity. Proc Natl Acad Sci U S A 1999; 96: 4089–94.
110. WindremMS, NunesMC, RashbaumWK, et al. Fetal and adult human oligodendrocyte progenitor cell isolates myelinate the congenitally dysmyelinated brain. Nat Med 2004; 10: 93–7.
111. GrovesAK, BarnettSC, FranklinRJ, et al. Repair of demyelinated lesions by transplantation of purified O-2A progenitor cells. Nature 1993; 362: 453–5.
112. LiuS, QuY, StewartTJ, et al. Embryonic stem cells differentiate into oligodendrocytes and myelinate in culture and after spinal cord transplantation. Proc Natl Acad Sci U S A 2000; 97: 6126–31.
113. EftekharpourE, Karimi-AbdolrezaeeS, WangJ, et al. Myelination of congenitally dysmyelinated spinal cord axons by adult neural precursor cells results in formation of nodes of Ranvier and improved axonal conduction. J Neurosci 2007; 27: 3416–28.
114. Karimi-AbdolrezaeeS, EftekharpourE, WangJ, et al. Delayed transplantation of adult neural precursor cells promotes remyelination and functional neurological recovery after spinal cord injury. J Neurosci 2006; 26: 3377–89.
115. Karimi-AbdolrezaeeS, EftekharpourE, WangJ, et al. Synergistic effects of transplanted adult neural stem/progenitor cells, chondroitinase, and growth factors promote functional repair and plasticity of the chronically injured spinal cord. J Neurosci 2010; 30: 1657–76.
116. CummingsBJ, UchidaN, TamakiSJ, et al. Human neural stem cells differentiate and promote locomotor recovery in spinal cord-injured mice. Proc Natl Acad Sci U S A 2005; 102: 14069–74.
117. HooshmandMJ, SontagCJ, UchidaN, et al. Analysis of host-mediated repair mechanisms after human CNS-stem cell transplantation for spinal cord injury: correlation of engraftment with recovery. PLoS One 2009; 4: e5871.
118. CaoQ, XuXM, DevriesWH, et al. Functional recovery in traumatic spinal cord injury after transplantation of multineurotrophin-expressing glial-restricted precursor cells. J Neurosci 2005; 25: 6947–57.
119. HuJG, WangXF, DengLX, et al. Co-transplantation of glial restricted precursor cells and Schwann cells promotes functional recovery after spinal cord injury. Cell Transplant 2013 [Epub ahead of print]
120. CaoQ, HeQ, WangY, et al. Transplantation of ciliary neurotrophic factor-expressing adult oligodendrocyte precursor cells promotes remyelination and functional recovery after spinal cord injury. J Neurosci 2010; 30: 2989–3001.
121. NistorGI, TotoiuMO, HaqueN, et al. Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation. Glia 2005; 49: 385–96.
122. SharpJ, FrameJ, SiegenthalerM, et al. Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants improve recovery after cervical spinal cord injury. Stem Cells 2010; 28: 152–63.
123. NaveKA. Myelination and the trophic support of long axons. Nat Rev Neurosci 2010; 11: 275–83.
124. PeknyM, NilssonM. Astrocyte activation and reactive gliosis. Glia 2005; 50: 427–34.
125. SofroniewMV. Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci 2009; 32: 638–47.
126. LeporeAC, O’DonnellJ, BonnerJF, et al. Spatial and temporal changes in promoter activity of the astrocyte glutamate transporter GLT1 following traumatic spinal cord injury. J Neurosci Res 2011; 89: 1001–17.
127. KliotM, SmithGM, SiegalJD, et al. Astrocyte-polymer implants promote regeneration of dorsal root fibers into the adult mammalian spinal cord. Exp Neurol 1990; 109: 57–69.
128. JoostenEA, VeldhuisWB, HamersFP. Collagen containing neonatal astrocytes stimulates regrowth of injured fibers and promotes modest locomotor recovery after spinal cord injury. J Neurosci Res 2004; 77: 127–42.
129. HanSS, LiuY, Tyler-PolszC, et al. Transplantation of glial-restricted precursor cells into the adult spinal cord: survival, glial-specific differentiation, and preferential migration in white matter. Glia 2004; 45: 1–16.
130. HillCE, ProschelC, NobleM, et al. Acute transplantation of glial-restricted precursor cells into spinal cord contusion injuries: survival, differentiation, and effects on lesion environment and axonal regeneration. Exp Neurol 2004; 190: 289–310.
131. NoutYS, CulpE, SchmidtMH, et al. Glial restricted precursor cell transplant with cyclic adenosine monophosphate improved some autonomic functions but resulted in a reduced graft size after spinal cord contusion injury in rats. Exp Neurol 2011; 227: 159–71.
132. DaviesJE, HuangC, ProschelC, et al. Astrocytes derived from glial-restricted precursors promote spinal cord repair. J Biol 2006; 5: 7.
133. DaviesJE, ProschelC, ZhangN, et al. Transplanted astrocytes derived from BMP- or CNTF-treated glial-restricted precursors have opposite effects on recovery and allodynia after spinal cord injury. J Biol 2008; 7: 24.
134. DaviesSJ, ShihCH, NobleM, et al. Transplantation of specific human astrocytes promotes functional recovery after spinal cord injury. PLoS One 2011; 6: e17328.
135. HaasC, NeuhuberB, YamagamiT, et al. Phenotypic analysis of astrocytes derived from glial restricted precursors and their impact on axon regeneration. Exp Neurol 2012; 233: 717–32.
136. JinY, NeuhuberB, SinghA, et al. Transplantation of human glial restricted progenitors and derived astrocytes into a contusion model of spinal cord injury. J Neurotrauma 2011; 28: 579–94.
137. SahniV, MukhopadhyayA, TysselingV, et al. BMPR1a and BMPR1b signaling exert opposing effects on gliosis after spinal cord injury. J Neurosci 2010; 30: 1839–55.
138. WeibleMW, Chan-LingT. Phenotypic characterization of neural stem cells from human fetal spinal cord: synergistic effect of LIF and BMP4 to generate astrocytes. Glia 2007; 55: 1156–68.
139. WangY, ChengX, HeQ, et al. Astrocytes from the contused spinal cord inhibit oligodendrocyte differentiation of adult oligodendrocyte precursor cells by increasing the expression of bone morphogenetic proteins. J Neurosci 2011; 31: 6053–8.
140. MatyashV, KettenmannH. Heterogeneity in astrocyte morphology and physiology. Brain Res Rev 2010; 63: 2–10.
141. TsaiHH, LiH, FuentealbaLC, et al. Regional astrocyte allocation regulates CNS synaptogenesis and repair. Science 2012; 337: 358–62.
142. HanSS, KangDY, MujtabaT, et al. Grafted lineage-restricted precursors differentiate exclusively into neurons in the adult spinal cord. Exp Neurol 2002; 177: 360–75.
143. CaoQ-L, HowardRM, DennisonJB, et al. Differentiation of engrafted neuronal-restricted precursor cells is inhibited in the traumatically injured spinal cord. Exp Neurol 2002; 177: 349–59.
144. LeporeAC, NeuhuberB, ConnorsTM, et al. Long-term fate of neural precursor cells following transplantation into developing and adult CNS. Neuroscience 2006; 142: 287–304.
145. BonnerJF, ConnorsTM, SilvermanWF, et al. Grafted neural progenitors integrate and restore synaptic connectivity across the injured spinal cord. J Neurosci 2011; 31: 4675–86.
146. NistorG, SiegenthalerMM, PoirierSN, et al. Derivation of high purity neuronal progenitors from human embryonic stem cells. PLoS One 2011; 6: e20692.
147. TsujiO, MiuraK, OkadaY, et al. Therapeutic potential of appropriately evaluated safe-induced pluripotent stem cells for spinal cord injury. Proc Natl Acad Sci U S A 2010; 107: 12704–9.
148. HarperJM, KrishnanC, DarmanJS, et al. Axonal growth of embryonic stem cell-derived motoneurons in vitro and in motoneuron-injured adult rats. Proc Natl Acad Sci U S A 2004; 101: 7123–8.
149. KerrDA, LladoJ, ShamblottMJ, et al. Human embryonic germ cell derivatives facilitate motor recovery of rats with diffuse motor neuron injury. J Neurosci 2003; 23: 5131–40.
150. DeshpandeDM, KimYS, MartinezT, et al. Recovery from paralysis in adult rats using embryonic stem cells. Ann Neurol 2006; 60: 32–44.
151. RossiSL, NistorG, WyattT, et al. Histological and functional benefit following transplantation of motor neuron progenitors to the injured rat spinal cord. PLoS One 2010; 5: e11852.
152. PolgarE, HughesDI, RiddellJS, et al. Selective loss of spinal GABAergic or glycinergic neurons is not necessary for development of thermal hyperalgesia in the chronic constriction injury model of neuropathic pain. Pain 2003; 104: 229–39.
153. MeisnerJG, MarshAD, MarshDR. Loss of GABAergic interneurons in laminae I-III of the spinal cord dorsal horn contributes to reduced GABAergic tone and neuropathic pain after spinal cord injury. J Neurotrauma 2010; 27: 729–37.
154. SokalDM, ChapmanV. Inhibitory effects of spinal baclofen on spinal dorsal horn neurones in inflamed and neuropathic rats in vivo. Brain Res 2003; 987: 67–75.
155. KimDS, JungSJ, NamTS, et al. Transplantation of GABAergic neurons from ESCs attenuates tactile hypersensitivity following spinal cord injury. Stem Cells 2010; 28: 2099–108.
156. RoyNS, NakanoT, KeyoungHM, et al. Telomerase immortalization of neuronally restricted progenitor cells derived from the human fetal spinal cord. Nat Biotechnol 2004; 22: 297–305.
157. BonnerJF, BleschA, NeuhuberB, et al. Promoting directional axon growth from neural progenitors grafted into the injured spinal cord. J Neurosci Res 2010; 88: 1182–92.
158. TaylorL, JonesL, TuszynskiMH, et al. Neurotrophin-3 gradients established by lentiviral gene delivery promote short-distance axonal bridging beyond cellular grafts in the injured spinal cord. J Neurosci 2006; 26: 9713–21.
159. AltoLT, HavtonLA, ConnerJM, et al. Chemotropic guidance facilitates axonal regeneration and synapse formation after spinal cord injury. Nat Neurosci 2009; 12: 1106–13.
160. AbematsuM, TsujimuraK, YamanoM, et al. Neurons derived from transplanted neural stem cells restore disrupted neuronal circuitry in a mouse model of spinal cord injury. J Clin Invest 2010; 120: 3255–66.
161. LuP, WangY, GrahamL, et al. Long-distance growth and connectivity of neural stem cells after severe spinal cord injury. Cell 2012; 150: 1264–73.
162. BoyceVS, ParkJ, GageFH, et al. Differential effects of brain-derived neurotrophic factor and neurotrophin-3 on hindlimb function in paraplegic rats. Eur J Neurosci 2012; 35: 221–32.
163. HermannA, GastlR, LiebauS, et al. Efficient generation of neural stem cell-like cells from adult human bone marrow stromal cells. J Cell Sci 2004; 117: 4411–22.
164. BrazeltonTR, RossiFM, KeshetGI, et al. From marrow to brain: expression of neuronal phenotypes in adult mice. Science 2000; 290: 1775–9.
165. MezeyE, ChandrossKJ, HartaG, et al. Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow. Science 2000; 290: 1779–82.
166. JiangY, JahagirdarBN, ReinhardtRL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002; 418: 41–9.
167. LuP, BleschA, TuszynskiMH. Induction of bone marrow stromal cells to neurons: differentiation, transdifferentiation, or artifact? J Neurosci Res 2004; 77: 174–91.
168. NeuhuberB, GalloG, HowardL, et al. Reevaluation of in vitro differentiation protocols for bone marrow stromal cells: disruption of actin cytoskeleton induces rapid morphological changes and mimics neuronal phenotype. J Neurosci Res 2004; 77: 192–204.
169. Alvarez-DoladoM, PardalR, Garcia-VerdugoJM, et al. Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature 2003; 425: 968–73.
170. CastroRF, JacksonKA, GoodellMA, et al. Failure of bone marrow cells to transdifferentiate into neural cells in vivo. Science 2002; 297: 1299.
171. HofstetterCP, SchwarzEJ, HessD, et al. Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery. Proc Natl Acad Sci U S A 2002; 99: 2199–204.
172. BohlD, LiuS, BlanchardS, et al. Directed evolution of motor neurons from genetically engineered neural precursors. Stem Cells 2008; 26: 2564–75.
173. VierbuchenT, OstermeierA, PangZP, et al. Direct conversion of fibroblasts to functional neurons by defined factors. Nature 2010; 463: 1035–41.
174. RichardJP, ZurynS, FischerN, et al. Direct in vivo cellular reprogramming involves transition through discrete, non-pluripotent steps. Development 2011; 138: 1483–92.
175. MartensDJ, SeabergRM, van der KooyD. In vivo infusions of exogenous growth factors into the fourth ventricle of the adult mouse brain increase the proliferation of neural progenitors around the fourth ventricle and the central canal of the spinal cord. Eur J Neurosci 2002; 16: 1045–57.
176. KojimaA, TatorCH. Epidermal growth factor and fibroblast growth factor 2 cause proliferation of ependymal precursor cells in the adult rat spinal cord in vivo. J Neuropathol Exp Neurol 2000; 59: 687–97.
177. YamamotoS, NagaoM, SugimoriM, et al. Transcription factor expression and Notch-dependent regulation of neural progenitors in the adult rat spinal cord. J Neurosci 2001; 21: 9814–23.
178. LipsonAC, HornerPJ. Potent possibilities: endogenous stem cells in the adult spinal cord. Prog Brain Res 2002; 137: 283–97.
179. Barnabe-HeiderF, GoritzC, SabelstromH, et al. Origin of new glial cells in intact and injured adult spinal cord. Cell Stem Cell 2010; 7: 470–82.
180. ObermairFJ, SchroterA, ThallmairM. Endogenous neural progenitor cells as therapeutic target after spinal cord injury. Physiology (Bethesda) 2008; 23: 296–304.
181. WuB, RenX. Promoting axonal myelination for improving neurological recovery in spinal cord injury. J Neurotrauma 2009; 26: 1847–56.
182. OhoriY, YamamotoS, NagaoM, et al. Growth factor treatment and genetic manipulation stimulate neurogenesis and oligodendrogenesis by endogenous neural progenitors in the injured adult spinal cord. J Neurosci 2006; 26: 11948–60.
183. SongH, StevensCF, GageFH. Astroglia induce neurogenesis from adult neural stem cells. Nature 2002; 417: 39–44.
184. PluchinoS, QuattriniA, BrambillaE, et al. Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis. Nature 2003; 422: 688–94.
185. WuS, SuzukiY, NodaT, et al. Immunohistochemical and electron microscopic study of invasion and differentiation in spinal cord lesion of neural stem cells grafted through cerebrospinal fluid in rat. J Neurosci Res 2002; 69: 940–5.
186. De la CalleJL, MenaMA, Gonzalez-EscaladaJR, et al. Intrathecal transplantation of neuroblastoma cells decreases heat hyperalgesia and cold allodynia in a rat model of neuropathic pain. Brain Res Bull 2002; 59: 205–11.
187. BartholdiD, RubinBP, SchwabME. VEGF mRNA induction correlates with changes in the vascular architecture upon spinal cord damage in the rat. Eur J Neurosci 1997; 9: 2549–60.
188. AarumJ, SandbergK, HaeberleinSLB, et al. Migration and differentiation of neural precursor cells can be directed by microglia. Proc Natl Acad Sci U S A 2003; 100: 15983–8.
189. EhteshamM, YuanX, KabosP, et al. Glioma tropic neural stem cells consist of astrocytic precursors and their migratory capacity is mediated by CXCR4. Neoplasia 2004; 6: 287–93.
190. Ben-HurT, Ben-MenachemO, FurerV, et al. Effects of proinflammatory cytokines on the growth, fate, and motility of multipotential neural precursor cells. Mol Cell Neurosci 2003; 24: 623–31.
191. Forsberg-NilssonK, BeharTN, AfrakhteM, et al. Platelet-derived growth factor induces chemotaxis of neuroepithelial stem cells. J Neurosci Res 1998; 53: 521–30.
192. LeporeAC, BakshiA, SwangerSA, et al. Neural precursor cells can be delivered into the injured cervical spinal cord by intrathecal injection at the lumbar cord. Brain Res 2005; 1045: 206–16.
193. Keyvan-FouladiN, RaismanG, LiY. Functional repair of the corticospinal tract by delayed transplantation of olfactory ensheathing cells in adult rats. J Neurosci 2003; 23: 9428–34.
194. StraussS. Geron trial resumes, but standards for stem cell trials remain elusive. Nat Biotechnol 2010; 28: 989–90.
195. WirthE, LebkowskiJS, LebacqzK. Target populations for first-in-human embryonic stem cell research in spinal cord injury. Cell Stem Cell 2011; 8: 476–8.
196. SolbakkJH, ZolothL. The tragedy of translation: the case of “first use” in human embryonic stem cell research. Cell Stem Cell 2011; 8: 479–81.
197. BretznerF, GilbertF, BaylisF, et al. Target populations for first-in-human embryonic stem cell research in spinal cord injury. Cell Stem Cell 2011; 8: 468–75.
198. DaleyGQ, Ahrlund RichterL, AuerbachJM, et al. Ethics. The ISSCR guidelines for human embryonic stem cell research. Science 2007; 315: 603–4.
199. HyunI, LindvallO, Ahrlund-RichterL, et al. New ISSCR guidelines underscore major principles for responsible translational stem cell research. Cell Stem Cell 2008; 3: 607–9.
200. (ICCP) ICfCosciP. Experimental treatments for spinal cord injury: what you should know if you are considering participation in a clinical trial. 2007. Available from:
201. DobkinBH, CurtA, GuestJ. Cellular transplants in China: observational study from the largest human experiment in chronic spinal cord injury. Neurorehabil Neural Repair 2006; 20: 5–13.